-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
(1554) Views (354) Full article downloads
Authors: Annyce S Mayer, James K Stoller, Sverre Vedal, A James Ruttenber, Matt Strand, et al
Published Date May 2006
Volume 2006:1(4) Pages 485 - 492
DOI: http://dx.doi.org/10.2147/COPD.S
Annyce S Mayer1, James K Stoller5, Sverre Vedal6, A James Ruttenber4, Matt Strand3, Robert A Sandhaus2, Lee S Newman4
1Division of Environmental and Occupational Health Sciences; 2Department of Medicine; 3Division of Biostatistics, National Jewish Medical and Research Center, Denver, CO, USA; 4Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, Denver, CO, USA; 5Section of Respiratory Therapy, Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA; 6Environmental Health, Roosevelt, University of Washington, Seattle, WA, USA
Background: In an early study of highly symptomatic patients with PI*Z alpha-1 antitrypsin deficiency (AAT), tobacco smoking was identified as a risk factor by comparing the age of symptom onset in smokers and nonsmokers. Age of symptom onset has not been well studied in relationship to other environmental exposures.
Methods: Environmental exposures were assessed in 313 PI*Z adults through retrospective self-administered questionnaire. Age of onset of symptoms with and without these exposures were analyzed through survival analysis.
Results: Personal smoking was the most important risk factor, associated with earlier onset of cough and wheeze, and showed a dose-dependent relationship with the onset of dyspnea. Childhood environmental tobacco smoke (ETS) exposure was independently associated with younger age of onset of cough. Earlier onset of wheeze was also associated with childhood respiratory infections and family history of emphysema. The report of childhood respiratory infections was associated with childhood ETS exposure, but no statistically significant interactions were noted.
Conclusions: We conclude that both personal and secondhand exposure to tobacco smoke in childhood are likely to accelerate the onset of symptoms in AAT deficient patients. Respiratory infections in childhood may also contribute to this risk.
Keywords: alpha-1 antitrypsin deficiency, tobacco smoke pollution, respiratory symptoms, lower respiratory illness.
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




